Clinical Trial Update: Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC)

View source ↗

Summary

This clinical trial update describes a study using multimodal artificial intelligence to predict response to neoadjuvant immunotherapy in gastric cancer, with t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: Qun Zhao | Conditions: Gastric Cancer (GC), Locally Advanced Gastric Cancer | Status: NOT_YET_RECRUITING